Search research articles
Contact Us
Filters
Showing results (41-50 of 113) with videos related to
Page
of 12
Sort By:
Archives of Physical Medicine and Rehabilitation
|
September 8, 2014
Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial
Kerri M Winters-Stone, Jessica C Dobek, Jill A Bennett, et al.
BJU International
|
September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer
Joseph S Chan, Tomasz M Beer, David I Quinn, et al.
Cancer
|
January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinoma
Lisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research
|
November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer
Jonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
Cancer
|
December 19, 2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
Robert W Ross, Tomasz M Beer, Susanna Jacobus, et al.
The Journal of Urology
|
January 13, 2006
Testosterone loss and estradiol administration modify memory in men
Tomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study
Nancy B Davis, David A Taber, Rafat H Ansari, et al.
Cancer Chemotherapy and Pharmacology
|
March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma
Christopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer
Tomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
BMC Cancer
|
June 25, 2026
Remotely delivered resistance training program in adult sarcoma survivors: a pilot study
Lara E Davis, Shannon C Austin, James B Hayden, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 113) with videos related to
Sort By:
Page
of 12
Archives of Physical Medicine and Rehabilitation
|
September 8, 2014
Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial
Kerri M Winters-Stone, Jessica C Dobek, Jill A Bennett, et al.
BJU International
|
September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer
Joseph S Chan, Tomasz M Beer, David I Quinn, et al.
Cancer
|
January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinoma
Lisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research
|
November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer
Jonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
Cancer
|
December 19, 2007
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
Robert W Ross, Tomasz M Beer, Susanna Jacobus, et al.
The Journal of Urology
|
January 13, 2006
Testosterone loss and estradiol administration modify memory in men
Tomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study
Nancy B Davis, David A Taber, Rafat H Ansari, et al.
Cancer Chemotherapy and Pharmacology
|
March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma
Christopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer
Tomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
BMC Cancer
|
June 25, 2026
Remotely delivered resistance training program in adult sarcoma survivors: a pilot study
Lara E Davis, Shannon C Austin, James B Hayden, et al.
Page
of 12